Evidence map›Paper›PMID 17689379›Full record

ArticleThe International journal on drug policy2007

Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services.

Laurie Sylla, R Douglas Bruce, Adeeba Kamarulzaman, Frederick L Altice

Open access · greenAbstract read
In one paragraph

Article in The International journal on drug policy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 6 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 6 syntheses or guidelines pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Observational

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Laurie SyllaYale University AIDS Programme, 135 College Street, Suite 323, New Haven, CT 06510, United States.
R Douglas Bruce
Adeeba Kamarulzaman
Frederick L Altice
Yale University · US

Funding

Enhancing Health Outcomes Among HIV+ Substance AbusersK24DA017072 · NIDA · YALE UNIVERSITY · PI ALTICE, FREDERICK LEWIS · 2003 to 2012
$1.5M
Substance Abuse, HIV and HCV Treatments to Improve Health Outcomes in Drug UsersK23DA022143 · NIDA · YALE UNIVERSITY · PI BRUCE, ROBERT D · 2006 to 2010
$881k
Buprenorphine Treatment Expansion in HIV Clinical Setti*H79TI015767 · SU · CHEMICAL ABUSE SERVICES AGENCY, INC. · PI DELERME, ASHER · 2007 to 2007
–
CSAT SAMHSA HHS H79 TI 15767NIDA NIH HHS K23 DA022143NIDA NIH HHS K23-DA 022143NIDA NIH HHS K24 DA017072NIDA NIH HHS K24-DA 017072
6 · The paper itself

Abstract

Injection drug use (IDU) plays a critical role in the HIV epidemic in several countries throughout the world. In these countries, injection drug users are at significant risk for both HIV and tuberculosis, and active IDU negatively impacts treatment access, adherence and retention. Comprehensive strategies are therefore needed to effectively deliver preventive, diagnostic and curative services to these complex patient populations. We propose that developing co-located integrated care delivery systems should become the focus of national programmes as they continue to scale-up access to antiretroviral medications for drug users. Existing data suggest that such a programme will expand services for each of these diseases; increase detection of tuberculosis (TB) and HIV; improve medication adherence; increase entry into substance use treatment; decrease the likelihood of adverse drug events; and improve the effectiveness of prevention interventions. Key aspects of integration programmes include: co-location of services convenient to the patient; provision of effective substance use treatment, including pharmacotherapies; cross-training of generalist and specialist care providers; and provision of enhanced monitoring of drug-drug interactions and adverse side effects. Central to implementing this agenda will be fostering the political will to fund infrastructure and service delivery, expanding street-level outreach to IDUs, and training community health workers capable of cost effectively delivering these services.

Indexed as

HIV InfectionsTuberculosis, PulmonaryAcquired Immunodeficiency SyndromeAnti-Retroviral AgentsAntitubercular AgentsHumansPreventive Health ServicesPrimary Health CareProgram DevelopmentSubstance-Related DisordersVulnerable PopulationsAnti-Retroviral AgentsAntitubercular Agents

Identifiers

PMID17689379
PMCPMC2696234
OpenAlexW2142481435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.